1. Market Perspective on Recent Developments in the TRIPS and Essential Medicines Debate / Owen Lippert
2. Economics of TRIPS Options for Access to Medicines / F. M. Scherer and Jayashree Watal
3. Parallel Trade in Pharmaceutical Products: Implications for Procuring Medicines for Poor Countries / Keith E. Maskus and Mattias Ganslandt
4. Fatal Side Effects: Medicine Patents Under the Microscope / Oxfam
5. Patents, Patients and Developing Countries: Access, Innovation and the Political Dimensions of Trade Policy / Harvey E. Bale, Jr.
6. Developing States' Responses to the Pharmaceutical Imperatives of the TRIPS Agreement / Jillian Clare Cohen
7. Pharmaceutical Sector: The Generics Development Trajectory / Brigitte Granville and Carol Leonard
8. Development Trilemma and the South African Response / W. Duncan Reekie
9. Expanding Access to Essential Medicines in Brazil: Recent Economic Regulation, Policy-Making and Lessons Learnt / Jorge Bermudez
10. Challenges in Widening Access to HIV-AIDS-Related Drugs and Care in Uganda / Dorothy Ochola
11. Differential Pricing and the Financing of Essential Drugs / WHO-WTO
12. International Effort for Anti-Retrovirals: Politics or Public Health? / Louisiana Lush
13. Providing Health Care to HIV Patients in Southern Africa / Markus Haacker
14. Successful public-private partnerships in global health: lessons from the MECTIZAN Donation Program / Jeffrey L. Sturchio and Brenda D. Colatrella
15. Street Price: A Global Approach to Drug Pricing for Developing Countries / Anna Thomas.
